![Axial Biotherapeutics Raises $25 Million in Series B Financing](https://www.seventure.fr/wp-content/uploads/2019/02/4__104270789-322x211.jpg)
Axial Biotherapeutics Raises $25 Million in Series B Financing
Funds will be used to advance Axial’s gut-targeted programs in Parkinson’s Disease and Autism Spectrum Disorder. Seventure Partners commits new funding from...
Search
All
Funds will be used to advance Axial’s gut-targeted programs in Parkinson’s Disease and Autism Spectrum Disorder. Seventure Partners commits new funding from...
Health for Life Capital II™ to focus on the microbiome, and health, nutrition and digital/connected health sectors.
Seventure Partners, one of Europe’s leaders in financing innovation and a world-leader in the venture investment in the microbiome sector, is pleased to provide an update on...
Phage therapy company BiomX Ltd. (Ness Ziona, Israel) raised a $32 million series B round on Wednesday, 20th February, that will take its lead candidate, acne therapy BX001,...
Seventure Keeps up Pace of Its International Microbiome Investments, Closing Four Deals Spanning Seed to Series C
Vedanta Bioscience, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human...
The latest investment will help drive expansion and accelerate research & development to introduce new and novel ingredients to the market.
The $30 million in new investment will fuel expansion and accelerate R&D project execution. This funding round opens up an opportunity to explore different ways to meet...
A-Mansia Biotech, a microbiome company, has announced the appointment of Cees de Jong as the Chairman of its Board of Directors. His experience of successfully managing several...
It's a decisive step in BALYO’s development that supports the added value of BALYO’s robotic solutions and will potentially boost their deployment. AMAZON would obtain the...